FMC reports second-quarter results on July 30 with short sellers sitting at their most aggressive in months and the Street trimming targets into the print.
The short position has become the dominant story. Short interest jumped 7% over the past week to 21.9% of the free float — and the 30-day move is more striking still, up 55% from roughly 14% of float at the end of June to the current level. That near-doubling of bearish positioning in a single month is the fastest build the stock has seen in this data window. Days-to-cover stand at six, meaning shorts would need more than a full trading week to exit at average volumes. What's notable is that this pressure exists despite a relatively loose lending market: availability runs at roughly 407% — meaning four times as many shares remain available to borrow as are already on loan — and the cost to borrow is just 0.50%, near its lowest level in 30 days. Shorts aren't facing a squeeze. They're building into an easy borrow, which makes the conviction look deliberate rather than structural.
Options traders are fractionally more defensive than usual but not alarmed. The put/call ratio ticked up to 0.32 on Tuesday — about 1.4 standard deviations above its 20-day average of 0.31 — and is close to its 52-week low of 0.30. That level of call dominance suggests options flow is not hedging aggressively ahead of the print; the incremental shift is modest. The combined signal — shorts piling in, options market relatively calm — points to directional bearishness from the short book rather than broad-based fear.
The Street has turned more cautious in the run-up to earnings. Barclays cut its target from $13 to $11 on July 27, maintaining an Underweight rating at a level now only marginally above the current price of $10.94. RBC trimmed from $14 to $12 last week. The consensus target of $15.57 implies meaningful upside from here, but that figure is anchored by Goldman Sachs' $21 Buy-rated target from April — a level set before the recent leg lower. The direction of travel from most desks is downward, and the Barclays target suggests the downside scenario is not yet fully priced in. Factor scores reinforce the bear case: FMC ranks in the 3rd percentile on short score and the 4th percentile on EV/EBIT, while earnings momentum scores are weak at 17 (30-day) and 26 (90-day). The one bright spot is EPS surprise, which ranks in the 97th percentile — the company has consistently beaten estimates even as the share price has deteriorated. Valuation is distressed rather than cheap: price-to-book is 0.69 and EV/EBITDA is 6.9x, both compressing over the past month.
The institutional picture adds one layer of interest. BlackRock added 3.3 million shares in the quarter to June 30, lifting its stake to nearly 15% of outstanding shares. AQR built an almost entirely new position of 9.2 million shares in Q1. Both moves suggest quant and index money is accumulating — though the timing of those filings means neither reflects the sharp short-interest increase of the last 30 days.
Earnings history offers a cautious frame. The May 1 print saw the stock fall 5.3% on the day and another 12.9% over the following five sessions — the bear case on Brazilian competition and below-consensus guidance hitting hard. The April 30 print was the reverse intraday — up 1.2% — but reversed to a 6.6% loss by the end of the following week. The pattern suggests FMC's post-earnings moves tend to resolve lower on a five-day horizon even when the initial reaction is positive. Peers have mostly moved the other way this week: CTVA gained 2.3% and MOS added 5.1%, while OLN fell 7.7% — sector moves are mixed rather than uniformly negative, which puts FMC's 3.8% weekly decline in sharper relief.
The July 30 print is the fulcrum: the key question is whether H2 EBITDA recovery guidance — management's stated path to ~$600 million in the back half — holds up after the first half's pricing and volume disappointments, or whether the shorts building at 21.9% of float find their thesis confirmed.
See the live data behind this article on ORTEX.
Open FMC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
